02 January 2025
02 January 2025
With this funding, Patho Care aims to expand its service range in the diagnostics testing sector.
The company plans to initiate a limited launch of the device in targeted regions next year.
The combination of implantable devices with AI-enabled wearable technology is spurring market growth.
The device is intended for use in complex laparoscopic surgeries by providing surgeons with ‘unprecedented precision’.
Too many alarms on the AquaFlexFlow UF 500 Plus could terminate therapy, leading to hypovolemia or dehydration.
A US court previously found that NanoString – acquired by Bruker earlier this year – infringed on patented technology developed by 10x Genomics.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
